Results 101 to 110 of about 16,685 (240)

Prognosis and management of polymyalgia rheumatica

Universa Medicina, 2016
Polymyalgia rheumatica (PMR) is commonly found in Northern Europe and in persons of Scandinavian extraction in the US, with an annual incidence of around 50 per 100,000 population over 50 years of age, in whom it should be           considered in the ...
Diana Samara
doaj   +1 more source

Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica

Frontiers in Immunology, 2019
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are inflammatory diseases requiring long-term glucocorticoid treatment. Limited data on dynamics in leukocyte counts before, during and after treatment are available.
Y. van Sleen, J. Graver, W. Abdulahad, K. V. D. van der Geest, A. Boots, M. Sandovici, E. Brouwer   +6 more
semanticscholar   +1 more source

Patient-reported Outcomes in Polymyalgia Rheumatica [PDF]

, 2012
Eric L. Matteson, Hilal Maradit Kremers, Marco A. Cimmino, Wolfgang Schmidt, Michael Schirmer, Carlo Salvarani, Artur Bachta, Christian Dejaco, Christina Duftner, Hanne Jensen, Gyula Poór, Novák Pál Kaposi, Péter Mandl, P Bálint, Zsuzsa Schmidt, Annamaria Iagnocco, Fabrizio Cantini, Carlotta Nannini, Pierluigi Macchioni, Nicolò Pipitone, Montserrat Del Amo, Georgina Espígol‐Frigolé, María C. Cid, Víctor M. Martínez‐Taboada, Elisabeth Nordborg, Haner Di̇reskeneli̇, Sibel Zehra Aydın, Khalid Ahmed, B L Hazelman, Colin Pease, Richard J. Wakefield, Raashid Luqmani, Andy Abril, Ralph Marcus, Neil Gonter, Mehrdad Maz, Cynthia S. Crowson, Bhaskar Dasgupta   +37 more
openalex   +1 more source

After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?

Reumatismo
Dear Editor, the number of cases of cancer patients diagnosed as having immune checkpoint inhibitor-mediated polymyalgia rheumatica has been steadily rising in published reports.
Ciro Manzo, Marco Isetta
doaj   +1 more source

Polymyalgia Rheumatica Post-SARS-CoV-2 Infection

Case Reports in Immunology
There is growing evidence that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to dysregulation of the immune system and, consequently, the development of autoimmune phenomena.
Carolina Duarte-Salazar, José Eugenio Vazquez-Meraz, Lucio Ventura-Ríos, Cristina Hernández-Díaz, José Arellano-Galindo   +4 more
doaj   +1 more source

Outcomes of polymyalgia rheumatica in real-world practice: a longitudinal cohort study

Romanian Journal of Internal Medicine
Background: Polymyalgia rheumatica (PMR) is an inflammatory condition closely linked with giant cell arteritis, which is a large vessel vasculitis. To provide real-world evidence on PMR outcomes and their determinants, we conducted a longitudinal study ...
Rahimi Mehran, Esalatmanesh Kamal, Daneshvar Sara, Irvani Seyed Sina Naghibi, Badali Ahmadreza, Khabbazi Alireza   +5 more
doaj   +1 more source

Polymyalgia rheumatica during the course of limited cutaneous scleroderma: an unusual and challenging coexistence

European Journal of Case Reports in Internal Medicine
A 50-year-old patient with a history of limited cutaneous scleroderma began with polyarthralgia (left shoulder, elbows and hips) without stiffness or associated inflammatory syndrome.
Noel Lorenzo-Villalba, Charlene Habib, Léa Docquier, Edward Nasco, Alessio Imperiale, Emmanuel Andrès, Jean Edouard Terrade   +6 more
doaj   +1 more source

Are the New ACR/EULAR Criteria the Ultimate Answer for Polymyalgia Rheumatica Classification? [PDF]

, 2016
Dario Camellino, Marco A. Cimmino
openalex   +1 more source

Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? [PDF]

, 1996
Synovium, F Kozin, D Mccarty, D Mccarty, D S Owen, Jr, E Toone, R Irby, H Bloch-Michelle, M Benoist, J Ripauult, J Siaud, M Schwartzberg, D H Lieberman, V P Gupta, G Ehrlich, D J Wallace, J Klinenberg, D Morhaim, B Berlanstein, P Biren, G Callis, A Rizzoli, L Trujeque, A Bankhurst, Jessee, F Toone, E Owen, D S Irby, R, M Atdjian, F Fernandez-Madrid, D Raman, A Abdalla, Newton Haslock, I, R Waterworth, T P Gordon, M Ahern, C Reid, P Roberts-Thompson, E Martinez-Cordero, A Bessudo-Babani, Trevifto-P6rez S C, Guillermo Grajales, E, K Spector, R Christman, D Wendling, M Guidet, H Talbott, Y Altman R D, Ts'ai-Fan, A Lussier, Medicis De R, T Yu, P Simkin, F Campbell, E Larson, K Strader, C Agudelo, G Macfarlane, A Dieppe, J Curran, F Renold, L Meyers 0, F S E Monteagudo, Ter Borg, E J Rasker, J   +68 more
openalex   +3 more sources

Prognosis and management of polymyalgia rheumatica [PDF]

Universa Medicina, 2011
Polymyalgia rheumatica (PMR) is commonly found in Northern Europe and in persons of Scandinavian extraction in the US, with an annual incidence of around 50 per 100,000 population over 50 years of age, in whom it should be considered in the ...
Diana Samara
doaj